Reviving the Weizmann process for commercial n-butanol production by unknown
ARTICLE
Reviving the Weizmann process for commercial
n-butanol production
Ngoc-Phuong-Thao Nguyen1,2,3,4, Céline Raynaud5, Isabelle Meynial-Salles1,2,3 & Philippe Soucaille1,2,3,5,6
Developing a commercial process for the biological production of n-butanol is challenging as
it needs to combine high titer, yield, and productivities. Here we engineer Clostridium acet-
obutylicum to stably and continuously produce n-butanol on a mineral media with glucose as
sole carbon source. We further design a continuous process for fermentation of high con-
centration glucose syrup using in situ extraction of alcohols by distillation under low pressure
and high cell density cultures to increase the titer, yield, and productivity of n-butanol pro-
duction to the level of 550 g/L, 0.35 g/g, and 14 g/L/hr, respectively. This process provides a
mean to produce n-butanol at performance levels comparable to that of corn wet milling
ethanol plants using yeast as a biocatalyst. It may hold the potential to be scaled-up at pilot
and industrial levels for the commercial production of n-butanol.
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The Weizmann process was developed at the beginning ofthe 20th century for the biological conversion of corn intoacetone and n-butanol by Clostridium acetobutylicum1–3. It
was the second largest fermentation process (after ethanol) of
enormous industrial, social and historical importance1–3. Beyond
its use during the First World War to produce acetone for
smokeless gunpowder (cordite) manufacturing, it became a pro-
cess used worldwide to produce these two industrial solvents
from a variety of renewable substrates3–5. Its demise in the early
1960s was the result of the superior petrochemical-process eco-
nomics due to drastic increase of the substrate costs1, the low
yield, titer, and productivity of the fermentation6 (resulting in
high operating and capital expenses), and the inability to use
continuous process technologies (as in the case of petrochemical
processes) due to the loss of C. acetobutylicum’s capacity to
produce solvents because of degeneration7,8.
Here we first use an advanced metabolic engineering approach
to engineer C. acetobutylicum to stably and continuously produce
n-butanol from glucose9. We further design a continuous process
for the fermentation of high concentration glucose syrup using (i)
in situ extraction of alcohols by distillation under low pressure,
and (ii) high cell density cultures to increase both the titer, yield,
and productivity of n-butanol production.
Results
Engineering C. acetobutylicum for the production of n-butanol.
This step requires to first eliminate the production of undesired
by-products namely butyrate, acetone, and lactate (Fig. 1a). In the
CAB1057 strain, we have then deleted ptb and buk that code
for the phosphotransbutyrylase and the butyrate kinase involved
in the last two steps of butyrate formation10–12, ctfAB that code
for the acetoacetyl-CoA-acetate CoA-transferase involved in the
first specific step of acetone formation13 and ldhA that codes for
the lactate dehydrogenase involved in the last step of L-lactate
formation13. When CAB1057 was evaluated in chemostat culture
and subjected to a metabolic flux analysis (Supplementary Fig. 1),
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Fig. 1 Metabolic engineering of Clostridium acetobutylicum for n-butanol production. a Elimination of by-products formation (strain CAB1057) by gene
deletion. ldhA lactate dehydrogenase, ctfAB acetoacetyl-CoA-acetate CoA-transferase, adc acetoacetate decarboxylase, ptb phosphotransbutyrylase, buk
butyrate kinase, adhE2 bifunctional NAD+-dependent aldehyde and alcohol dehydrogenase. b Optimization of acetyl-CoA conversion to n-butanol (Strain
CAB1060) using a chimeric pathway derived from three different microorganisms. Blue C. acetobutylicum; black E. coli, red C. kluyveri; Green boxes are Rex
binding sites. atoB acetoacetyl-CoA thiolase/synthase, hbd1 NADP+-dependent 3-hydroxybutyryl-CoA dehydrogenase, crt crotonase, bcd-etfAB butyryl-
CoA dehydrogenase
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the expected phenotype was obtained for the deleted pathways
but the n-butanol yield (Fig. 2a) and fluxes (Supplementary
Fig. 1) were not improved as this mutant produces more acetate
and ethanol than the wild-type strain. The redox-sensing tran-
scriptional repressor (Rex) has been found to modulate its DNA-
binding activity in response to the NADH/NAD+ ratio and to
repress the expression of several operons including thlA (that
codes for a thiolase), crt-bcd-etfAB-hbd, (that code, respectively,
for a crotonase, a butyryl-CoA dehydrogenase, and a 3-hydroxy-
butyryl-CoA dehydrogenase) and adhE2 (that codes for a
bifunctional aldehyde-alcohol14,15 (Fig. 1b)). As thlA and crt-bcd-
etfAB-hbd code for the enzymes converting acetyl-CoA to
butyryl-CoA and adhE2 codes for the enzyme that reduces
butyryl-CoA and acetyl-CoA to n-butanol and ethanol, respec-
tively, the rexA gene, encoding Rex, was deleted in CAB1057 (to
yield CAB1058) with the objective of improving the C4/C2 ratio
and the flux of alcohol formation. The yield and flux of alcohol
formation by CAB1058 were significantly improved, associated
with a four-fold decrease of the hydrogen yield and fluxes as the
electrons from reduced ferredoxin were mainly used for NADH
formation (Fig. 2a, Supplementary Fig. 1). However, the higher
alcohol yield was only due to an increase in the ethanol flux as the
n-butanol yield remained almost unchanged and, consequently,
the C4/C2 ratio was not improved (Fig. 2b). When the thiolase
(catalyzed by ThlA) and 3-hydroxy-butyryl-CoA dehydrogenase
(catalyzed by Hbd) activities were measured in CAB1057 and
CAB1058, ThlA remained unchanged while Hbd was 1.5 fold
higher), indicating that the rexA deletion has the expected effect
on the expression of the crt-bcd-etfAB-hbd operon coding for the
enzymes that convert acetoacetyl-CoA to butyryl-CoA) but not
on thlA. ThlA is one of the most abundant intracellular protein16
representing more than 5% of the cytosolic proteins. Further-
more, the condensation reaction by ThlA was shown to be very
sensitive to CoA-SH, with micro molar levels totally inhibiting
the enzyme17 and it was also found to be regulated by a redox-
switch through a reversible disulfide bond that is formed between
two catalytic cysteine residues (Cys88 and Cys378)18. As it might
be difficult to further overexpress ThlA and as its biochemical
properties might also contribute to the low C4/C2 ratio in
CAB1058 (Fig. 2b), ThlA was replaced by AtoB, a thiolase from E.
coli that has a higher catalytic efficiency, is less sensitive to CoA-
SH17,19,20 and not subject to a redox-switch. For this purpose, a
synthetic atoB gene was designed, codon harmonized21,22 for C.
acetobutylicum, and used to replace in frame thlA in CAB1058 (to
yield CAB1059). In CAB1059, the butanol to ethanol ratio (mol/
mol) and the butanol flux (in % of the glucose flux) only
increased from 0.59 to 0.84 (Fig. 2b) and from 45 to 55.1,
respectively, while the thiolase activity increased 1.7 fold (Sup-
plementary Fig. 2) suggesting that the C4/C2 ratio is not con-
trolled by the thiolase level or by the levels of the other enzymes
of the pathway and might be thermodynamically controlled. The
condensation of two acetyl-CoA to acetoacetyl-CoA catalyzed by
the thiolase is thermodynamically unfavorable23. Therefore, it is
important that acetoacetyl-CoA is efficiently reduced by Hbd
(Fig. 1b) to pull the reaction23. Hbd is an NADH-dependent
enzyme24 and, as it likely works near the thermodynamic
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Fig. 2 Optimization of the n-butanol-producing strain. All strains were evaluated in phosphate-limited chemostat cultures at pH 4.4 for wild type and 5.0
for all the other strains. All the engineered strain produced no acetone, lactate, and butyrate. a n-Butanol, acetate, hydrogen, and NAD(P)H from Fdred
yields (mol/mol glucose). b Product ratios (mol/mol). (C4+ C3)/C2= (Butanol+ Butyric acid+Acetone)/ (Ethanol+Acetic acid). Butanol selectivity=
Butanol/(Σ of all products except butanol). Error bars represent SD of three biological replicates
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equilibrium, the acetoacetyl-CoA/3-hydroxybutyryl-CoA ratio
will be dependent on the NADH/NAD+ ratio. As it has been
demonstrated in solventogenic C. acetobutylicum cells that the
NADPH/NADP+ ratio is at least 70 times higher than the
NADH/NAD+ ratio25, we anticipate that it would be advanta-
geous to replace Hbd by a strictly NADPH-dependent enzyme to
decrease the acetoacetyl-CoA/3-hydroxybutyryl-CoA ratio and
potentially improve the butanol/ethanol ratio. Such an enzyme
has been identified and characterized in Clostridium kluyveri26. In
strain CAB1060, we have replaced hbd by hbd1 from C. kluyveri.
A drastic improvement in the butanol/ethanol ratio (Fig. 2b) and
the n-butanol fluxes (Supplementary Fig. 1) were observed with,
respectively, 6- and 1.6-fold increase. Enzyme assays on crude
extract confirm that in the genetic modification of CAB1060,
the NADH-dependent 3-hydroxybutyryl-CoA dehydrogenase
activity was very low while the NADPH-dependent activity was
high; the reverse was observed for CAB1059 (Supplementary
Fig. 2). CAB1060 produces n-butanol at high yield (0.34 g/g)
(Table 1) in a simple mineral media without the addition of an
organic nitrogen source. Attempt to abolish acetate production in
the CAB1060 strain by either deleting pta and ack (that code for
the phospho-transacetylase and the acetate kinase involved in the
last two steps of acetate formation) or hydA that codes for the
main hydrogenase of C. acetobutylicum were unsuccessful sug-
gesting that such mutants were not viable. The pta-ack mutant
might not be viable due its inability to redirect all the electron
flow from hydrogen production to NADH production using the
Ferredoxin NAD+ reductase enzyme while the hydA mutant
might not be viable due to its inability to either avoid acetate
production or to re-oxidize reduced ferredoxin to produce
NADH or both. If a method to simultaneously inactivate several
genes would be available, it would have been interesting to delete
at the same time pta, ack, and hydA as such a strain might be
viable: eliminating both acetate and hydrogen would lead to a
strain converting glucose to butanol and ethanol with a perfectly
equilibrated redox balance.
The stability of CAB1060 was evaluated in chemostat culture.
We could maintain stable n-butanol (between 9 and 10 g/L) and
biomass concentrations (Fig. 3a) for more than 45 days and after
13 days of cultures only slight changes in the ethanol/acetate ratio
between 1 and 0.8 (mol/mol) were observed (Fig. 3a and
Supplementary Fig. 1).
Development of continuous process for n-butanol production.
Having a stable strain that produces n-butanol at a high yield in
a continuous culture is a prerequisite, but it is clearly not suf-
ficient for a commercial process as both the titer and the pro-
ductivities are too low. To improve those two parameters, several
methods of in situ butanol recovery including gas stripping,
vacuum fermentation, pervaporation, liquid–liquid extraction,
perstraction, and adsorption, have been investigated27. However,
high volumetric productivities or scaled-up industrial produc-
tion are still hard to achieve. We then envisioned a continuous
high cell density bioreactor with in situ extraction of the alcohols
(n-butanol+ ethanol) by distillation under low pressure
(0.18–0.46 × 104 Pa, for a boiler temperature regulated between
35 and 37 °C) without using any microfiltration membrane
(Fig. 4). The advantages of this method are (1) that the fer-
mentor is at atmospheric pressure which allows the fermentation
gas to be eliminated without pumping and limit the cost for low
pressure distillation compared to vacuum fermentation and (2)
high cell density can be obtained without the use of micro-
filtration membranes. Three runs of continuous extractive fer-
mentation were performed (Supplementary Table 1) but only the
run III will be presented in detail below. After an initial batch
phase without distillation, this setup was run in a fed-batch
mode by (i) starting vacuum distillation and (ii) exponentially
feeding the reactor with a medium at a high concentration of
glucose (~530 g/L) while maintaining full cell retention until
reaching an OD 600 nm of 90–100 (Fig. 3b), which corresponds
to ~28–30 g/L cell dry weight. As shown in Fig. 3b, the targeted
cell density was reached in ~70 hours after vacuum distillation
and feeding began, at which point a cell bleeding was imple-
mented at a dilution rate of 0.05 h−1 to maintain a constant cell
density and perform the fermentation in a continuous mode.
The concentration of n-butanol in the fermentor was between 9
and 10.5 g/L (Supplementary Fig. 3) while the average con-
centration of n-butanol in the butanol-rich phase that was
continuously collected was 550 g/L with concurrent average
Table 1 Representative studies of high level butanol production in C. acetobutylicum and C. beijerinckii
Strain Type Substrate/Medium Fermentation
Type
Butanol
Yield
(g/g)
Butanol
Titer
(g/L)
Butanol
Productivity
(g/L/hr)
Reference
C.acetobutylicum ATCC824 Wild type Glucose/synthetic medium Batch 0.18 10 0.25 Ref.38
C.acetobutylicum ATCC824 Wild type Glucose/synthetic medium+
1 mM MV
Batch 0.27 13.5 0.22 Ref.38
C.acetobutylicum ATCC824 Wild type Glucose/synthetic medium Continuous chemostat 0.185 8.8 1.1 Ref.33
C.acetobutylicum XY16 Wild type Glucose/complex medium Continuous immobilized 0.31 5.7 11.3 Ref.39
C.acetobutylicum ATCC824 Wild type Glucose/complex medium Continuous extractive
pervaporation
0.23 132 0.74 Ref.40
C.acetobutylicum ATCC824
(pGROE1)
Engineered Glucose/complex medium Batch NA 17.1 0.14 Ref.41
C.acetobutylicum HKKO Engineered Glucose/complex medium Batch 0.2 18.2 0.38 Ref.42
C.acetobutylicum BEKW
(pPthlAAD)
Engineered Glucose/complex medium Batch 0.29 18.9 0.33 Ref.43
C.acetobutylicum ATCC824
pfkA+ pykA
Engineered Glucose/complex medium Fed-batch 0.21 19.1 0.19 Ref.44
C.acetobutylicum BKM19 Engineered Glucose/complex medium Continuous cell recycle 0.17 11.9 10.7 Ref.45
C.acetobutylicum CAB1060 Engineered Glucose/synthetic medium Continuous extractive
distillation
0.35 550 14 This study
C. beijerinckii P260 Wild type Glucose/complex medium Batch 0.26 11.8 0.25 Ref.46
C. beijerinckii P260 Wild type Glucose/complex medium Batch vacuum fermentation 0.20 35.9 0.27 Ref.46
C. beijerinckii DSM 2152 Wild type Glucose/complex medium Continuous extractive gas
striping
0.19 NA 0.63 Ref.47
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ethanol and acetate titers of 60 and 3.3 g/L (Supplementary
Fig. 3). Starting at hour 70 and for 170 hours afterwards (i.e., up
to 240 hours of fermentation time), the volumetric productivities
of butanol and ethanol remained essentially constant, along with
the glucose volumetric consumption. For the three runs (Sup-
plementary Table 1), the average volumetric productivities of n-
butanol and ethanol were 14 and 1.5 g/L/hr, respectively, and the
average glucose volumetric consumption rate was 39.4 g/L/hr.
This resulted in an average n-butanol yield of 0.35 g/g (~84% of
the theoretical maximum) and n-butanol+ ethanol yield of 0.39
g/g28. Such high values of n-butanol productivities, titer, and
yield compare very well with the performances of the best corn
wet milling continuous industrial ethanol processes that display
ethanol titers of ~100 g/L, yield of 0.46 g/g (~90% of the theo-
retical maximum) and productivity of 10 g/L/hr29. In the US the
selling price of n-butanol is 2.3 times higher than ethanol ($1.2
per kg versus $0.5 per kg, ISIS data of September 2017) while the
yield of alcohol formation of our process is only 1.25 lower than
the ethanol process. If scaled-up at the industrial scale, the tech-
nology presented here should drastically decrease both the
operational and capital expenditure costs of the historical Weiz-
mann process and make the commercial production of n-butanol
economical and more attractive than the production of ethanol.
Methods
Bacterial strains, plasmids, and primers. The bacterial strain and plasmids used
in this study are listed in Supplementary Table 2 and Supplementary Table 3. The
specific oligonucleotides used for PCR amplification were synthesized by Euro-
gentec (Supplementary Table 4).
General protocol for gene deletion. Gene disruption in specified chromosomal
loci was carried out by homologous recombination13 with the modifications of
patent application WO2008/04038730. Deletion cassettes consisting of the
upstream homologous region-FRT-catP-FRT-downstream homologous region
were cloned in the pSOS95-MLSr-upp plasmid.
The pSOS95-MLSr-upp plasmids with the different deletion cassettes were used
to transform the successive recipient C. acetobutylicum strains which were
constructed from the MGCΔcac1502Δupp platform strain13.
As a general procedure, thiamphenicol-resistant transformants were selected on
CGM 50 g/L Glucose 0.1 M MES pH 6.1 (CGMMG) plates containing
thiamphenicol (10 μg/mL) (Tm). One colony was cultured for 24 hours in liquid
CGMMG with thiamphenicol (10 μg/mL) and 100 μL of undiluted culture was
plated on CGMMG with thiamphenicol (10 μg/mL) and 5-FU (1 mM). Colonies
resistant to both thiamphenicol and 5-FU were replica plated on both CGMMG
with thiamphenicol (5 μg/mL) and CGMMG with clarithromycin (40 μg/mL) to
select clones where 5-FU resistance is also associated with clarithromycin
sensitivity. The genotype of the clones resistant to thiamphenicol and sensitive to
clarithromycin was checked by PCR.
The catP resistance cassette was removed by transforming the strain with
plasmid pCLF1 expressing the flp1 gene encoding the Flp recombinase from
S. cerevisiae13. One colony of a clarithromycin resistant clone was cultured on
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Fig. 3 Continuous cultures of C. acetobutylicum CAB1060. a In phosphate-limited chemostat culture at pH 5, b in phosphate-limited high cell density culture
at pH 5 with in situ extraction of the alcohols (n-butanol+ ethanol) by distillation under low pressure. The arrow indicate the start of the cell bleeding. For
both continuous cultures, the initial batch phase is not presented
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liquid CGMMG without clarithromycin and the culture was plated on CGMMG
with 5-FU (1 mM). Colonies resistant to 5-FU were replica plated on CGMMG
with clarithromycin (40 μg/mL), CGMMG with thiamphenicol (10 μg/mL), and
CGMMG without antibiotic to select clones. The 5-FU resistance was associated
with the loss of the pCLF1 vector and the thiamphenicol sensitivity to the
elimination of the catP marker. The genotype of sensitive clones was checked
by PCR.
CAB1057 was constructed from the MGCΔcac1502Δupp platform strain by
successively applying this protocol to the deletion of ptb-buk, ctfAB, and
ldhA12,13,30. CAB1058 was constructed from CAB1057 by applying the same
protocol to the deletion of CA_C2713 encoding the Rex regulator and the removal
of the catP resistance cassette.
Construction of pEryuppatoB plasmid and CAB1059 strain. A synthetic atoB
operon coding for the AtoB thiolase of E. coli was synthesized as follow. A synthetic
atoB gene was designed with both an optimized synthetic RBS (translation
initiation rate was calculated to be 60217, a value similar to the translation
initiation rate of thlA) and a harmonized codon usage for C. acetobutylicum. The
synthetic gene was synthesized by Life technology (atoBs) with a BamHI site in
5′ and a SfoI site in 3′ and was cloned in a BamHI-SfoI digested pSOS95 to yield
pSOS95atoBs31.
The synthetic atoB gene was PCR amplified with the Phusion DNA polymerase
with pSOSatoBs as a template and the Atob-1 and Atob-2 oligonucleotides as
primers. This DNA fragment was directly cloned into the StuI linearized
pEryUppAthlA (for the construction of pEryUppAthlA22) by homologous
recombination using the GeneArt® Seamless Cloning & Assembly kit to yield the
pEryUppAtoB plasmid.
The pEryUppAtoB plasmid was used to transform by electroporation to
CAB1058 strain. After selection on Petri plates for clones having inserted the
pEryUppAtoB plasmid by homologous recombination (resistant to erythromycin
20 μg/mL), two colonies were cultured for 24 hours in CGM Glucose MES 0.1 M
medium. Appropriate dilutions were plated on CGM Glucose MES 0.1 M
(CGMMG) with 5-FU 1mΜ. To select integrants having excised and lost
pEryUppAtoB, 5-FU resistant clones were replica plated on both CGMMG with
5FU and CGMMG with erythromycin at 40 μg/mL. To identify clones having lost
pEryUppAtoB and possessing an atoB insertion, (clones resistant to 5-FU and
sensitive to erythromycin) were checked by PCR analysis (with primers Thl-0 and
Thl-5 located outside of the AthlA locus and Atob-1 and Atob-2 primers binding
specifically to atoB gene). The clones that had thlA replaced by atoB were isolated
to obtain pure clones to obtain CAB1059 strain.
Constructing pSOS95-upp-hbd1-catP-oriRepA and CAB1060 strains. To
amplify the two homologous regions flanking the CDS region of the hbd gene
on the genome of C. acetobutylicum ATCC824, two couples of primers (primer
1-hbd1-sacII/primer 2 and primer 5/primers 6-hbd1-sacII) were used. Two frag-
ments of 909 bp and 989 bp were obtained. Primer 3 and primer 4 were used to
amplify the hbd1 gene from genomic DNA of C. kluyveri DSM555 to obtain the
third fragment of 886 bp. Fragment 1 and 3 was fused by overlapping PCR using
primer 1-hbd1-sacII and primer 4 to obtain the fourth fragment of 1778 bp. After
that, this fourth fragment was fused with the second fragment by primer 1-hbd1-
sacII and primer 6-hbd1-sacII to produce the fifth fragment of 2692 bp.
The colE1 origin on pSOS95-MLSr-upp30 was replaced by the repA origin of
pSC101. The repA origin was amplified from pSC101 by two primers oriRepA-
XbaI-F and oriRepA-5’R to obtain a PCR product of 2296 bp. The partial
ampicillin resistant gene from pSOS95-upp was amplified by Amp3′-F and Amp-
ScaI-R to obtain a PCR product of 573 bp. The two resultant PCR fragment was
then fused by PCR using oriRepA-XbaI-F and Amp-ScaI-R. This 2849 bp fragment
was introduced to pSOS95-upp to replace repL fragment by digestion with XbaI
and ScaI restriction enzymes and ligation to obtain pSOS95-upp-orirepA. After
that, the homologous fragment containing hbd1 CDS was introduced to this
pSOS95-upp-orirepA by the SacII site to obtain pSOS95-hbd1-orirepA plasmid.
The catP cassette (flanking by FRT sequences) was inserted into the StuI site
carried by primer 4 and primer 5 in the homologous region to generate the final
plasmid pSOS95-hbd1-catP-oriRepA.
The final plasmid pSOS95-hbd1-catP-oriRepA was used to transform into
CAB1059 strain and followed the protocol presented above for the deletion30. The
transformants on plates CGMMG Thiamphenicol 10 μg/mL were selected and
checked by PCR for the single integration by two couples of primers etfB-3-F and
catP-3D or cac2706-3Rb and catP-5R. The integrants were spread on plates
CGMMG containing Thiamphenicol 10 μg/mL and 5-FU 1mM to promote the
second integration. Clones that were Thiamphenicol resistant and Clarithromycin
sensitive were selected and checked for double cross-over events by PCR using two
external primers etfB-3-F and cac2706-3Rb. The mutants were isolated to obtain
CAB1060-catP strain. After that, pCLF1 was introduced into CAB1060-catP strain
to remove catP cassette to generate the marker-less strain CAB1060.
Chemostat culture of recombinant strains. The strains were evaluated in
phosphate-limited continuous culture32 fed at 30 g/L glucose at a pH of 5.0.
Metabolic flux analysis was performed using the genome scale model previously
developed16.
Continuous extractive high density cell recycle fermentation. A 10% inoculum
of mid-exponential phase (OD600nm of 0.8–1.5) CAB1060 culture was used to
inoculate a 1 L glass bioreactor with a 0.5 L working volume of anaerobic synthetic
medium33 with 60 g/L glucose. Fermentation pH was controlled from dropping
below 5.0 using 4M NH4OH. Once the cultures reached an OD600nm of three,
extractive fermentation using low pressure distillation was initiated. Low pressure
distillation was accomplished by sending the whole broth to a 3 L Pyrex boiler
(0.3 L working volume) equipped34 to maintained a constant temperature (35–37 °
C) and a constant low pressure (0.18–0.46 × 104 Pa) above the boiler. The dis-
tillation column has an internal diameter of 7.8 cm, a height of 60 cm and was filed
with mesh column packing from Multiknit Ltd. The decanter was maintained at
2 °C, has a working volume of 0.1 L, and consists of a Pyrex tube with an internal
diameter of 2.4 cm and a height of 25 cm. The initial residence time of the broth in
the boiler was 0.5 hour. The fermenter was fed exponentially with a feed medium
(see the composition below) containing high glucose concentration (530 g/L) by
Feeding medium
[Glucose]=530 g/L
DE = 0.076 ±  0.003 h–1
Off gas
CO2 ~84%
H2 ~16%(mol.mol–1)
H2O rich
phase
Vaccum
0.18–0.46×104 Pa
Solvent rich phase
DS = 0.025 ± 0.001 h–1[Butanol]=550 ± 3 g/L
[Ethanol]=60.2 ± 2 g/L
(Acetic acid]=3.3 ± 0.2 g/L
Decanter
2°C
Boiler
36 ± 1°C
DR = 1.2–2.4 h–1
Fermentor
[X] = 29 ± 0.5 gDCW/L
[Butanol] = 10.1 ± 0.4 g/L
Cell bleeding = 0.051 ± 0.003h–1
[Butanol] = 1.1 ± 0.2 g/L
Fig. 4 Schematic representation of the extractive continuous fermentation process. The fermentor, boiler, and decantor have working volumes of 0.5 L,
0.3 L, and 0.1 L, respectively. For more details see Methods
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just keeping the volume of the fermentor constant. The distillate was condensed
(2 °C) and de-mixed in a butanol-rich- and a water-rich phase; the water-rich
phase was recycled to the distillation column while the butanol-rich phase was
collected. Once cell concentration reached an OD600nm of 90–100 (28–30 g/L cell
dry weight), a cell bleeding was started at a dilution rate of 0.05 h−1 while still
keeping volume of the fermenter constant by the addition of feed medium. The
residence time of the broth in the boiler was decreased to 0.25 h.
The feeding medium has the following composition (per liter of tap water):
glucose, 530 g; KH2PO4, 1.8 g; KCl, 5.7 g; MgSO4.7H2O, 3.6 g; FeSO4.7H2O, 0.5 g;
NH4Cl, 18 g; Biotin, 0.18 mg; and PAB, 0.14 g.
Measurement of fermentation parameters. Biomass concentration was deter-
mined by a DCW method that includes three steps: a centrifugation (16,000 g,
5 min, room temperature) of 1.5 mol broth in an Ependorf tube, two washes with
Milli-Q water, and drying under vacuum at 80 °C. The concentrations of glucose,
and of all the fermentation products were determined based on high-performance
liquid chromatography (HPLC)35 using a HPX87H (Biorad) column, H2SO4 at
0.5 mM, as mobile phase and a refractometer to quantify the different compounds.
Enzyme activity measurements. Cell crude extract of C. acetobutylicum mutants
was prepared in 100 mM Tris-HCl (pH 7.6), 5 mM dithiothreitol, and 2.5% gly-
cerol. The cell suspension was sonicated in an ultrasonic disintegrator (Vibracell
71434; Bioblock, Illkirch, France), at 0 °C in four cycles of 30 s with 2-min intervals
between each cycle. Cell debris was removed by three centrifugations at 13,000× g
for 5 min. The supernatant was loaded to PD10 column.
Thiolase activity was measured in the reverse thiolytic cleavage direction. The
reaction containing 0.1 M Tris-HCl pH8; 0.2 mM CoASH; 60 µM Acetoacetyl-CoA;
10 mM MgCl2; and 1 mM DTT and diluted crude extracts was incubated at 30 C
and followed the decrease of acetoacetyl-CoA at 303nm23,36. The enzyme activity
was calculated by the difference in the slope values of the sample and control and
using the molar extinction coefficient of 14,000 M−1 cm−1.
HBD activity was measured in the physiological direction36,37. The reaction
containing 0.1 mM MOPS (pH 7.0) buffer, 1 mM DTT, 0.1 mM acetoacetyl-CoA,
and 0.15 mM NADH, and crude extract at different dilution was incubated at
35 °C. The decreasing of NADH was followed spectrophotometrically at 345 nm.
The enzyme activity was calculated by the difference in the slope values of the
sample and control and using the molar extinction coefficient of 6220M−1 cm−1.
HBD1 activity was measured in the physiological direction26. Reaction
components were 0.1 M potassium phosphate, 25 mM potassium citrate, 0.15 mM
NADPH, 0.6 mM acetoacetyl-CoA, and crude extract. The assay was done at 35 °C
and the decrease of NADPH was followed at 340 nm. The molar extinction
coefficient of 6220M−1 cm−1 was used to calculate the enzyme activity.
Data availability
All relevant data are included with the manuscript (as figure or supplementary infor-
mation files). All data are available upon reasonable request from the corresponding
author.
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